View More Recent Stories
-
Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders
-
Roth/MKM Starts Cardiol Therapeutics (CRDL) at Buy
-
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT
-
Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
